Subscribe
shutterstock_749771347_scotyard
Scotyard / Shutterstock.com
9 September 2019AmericasSarah Morgan

Pharma industry challenges Canada’s drug pricing plan

Innovative Medicines Canada (IMC), an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility